Marloes Zoetemelk - Search Results

Year	Number of Results
2015	1
2016	1
2017	1
2018	1
2019	2
2020	4
2022	0

1

Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment.

Berndsen RH, Abdul UK, Weiss A, Zoetemelk M, Te Winkel MT, Dyson PJ, Griffioen AW, Nowak-Sliwinska P. Berndsen RH, et al. Among authors: zoetemelk m. Angiogenesis. 2017 May;20(2):245-267. doi: 10.1007/s10456-017-9551-z. Epub 2017 Apr 4. Angiogenesis. 2017. PMID: 28378227 Review.

2

Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment.

Zoetemelk M, Ramzy GM, Rausch M, Koessler T, van Beijnum JR, Weiss A, Mieville V, Piersma SR, de Haas RR, Delucinge-Vivier C, Andres A, Toso C, Henneman AA, Ragusa S, Petrova TV, Docquier M, McKee TA, Jimenez CR, Daali Y, Griffioen AW, Rubbia-Brandt L, Dietrich PY, Nowak-Sliwinska P. Zoetemelk M, et al. Mol Oncol. 2020 Nov;14(11):2894-2919. doi: 10.1002/1878-0261.12797. Epub 2020 Oct 5. Mol Oncol. 2020. PMID: 33021054 Free PMC article.

3

Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment.

Zoetemelk M, Ramzy GM, Rausch M, Nowak-Sliwinska P. Zoetemelk M, et al. Molecules. 2020 Jun 4;25(11):2614. doi: 10.3390/molecules25112614. Molecules. 2020. PMID: 32512790 Free PMC article.

4

Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance.

Rausch M, Weiss A, Zoetemelk M, Piersma SR, Jimenez CR, van Beijnum JR, Nowak-Sliwinska P. Rausch M, et al. Among authors: zoetemelk m. Cancers (Basel). 2020 Oct 28;12(11):3172. doi: 10.3390/cancers12113172. Cancers (Basel). 2020. PMID: 33126775 Free PMC article.

5

Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma.

Zoetemelk M, Rausch M, Colin DJ, Dormond O, Nowak-Sliwinska P. Zoetemelk M, et al. Sci Rep. 2019 May 8;9(1):7103. doi: 10.1038/s41598-019-42836-0. Sci Rep. 2019. PMID: 31068603 Free PMC article.

6

Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering.

Weiss A, Le Roux-Bourdieu M, Zoetemelk M, Ramzy GM, Rausch M, Harry D, Miljkovic-Licina M, Falamaki K, Wehrle-Haller B, Meraldi P, Nowak-Sliwinska P. Weiss A, et al. Among authors: zoetemelk m. Cancers (Basel). 2019 Oct 22;11(10):1612. doi: 10.3390/cancers11101612. Cancers (Basel). 2019. PMID: 31652588 Free PMC article.

7

Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.

Berenguer J, Lagerweij T, Zhao XW, Dusoswa S, van der Stoop P, Westerman B, de Gooijer MC, Zoetemelk M, Zomer A, Crommentuijn MHW, Wedekind LE, López-López À, Giovanazzi A, Bruch-Oms M, van der Meulen-Muileman IH, Reijmers RM, van Kuppevelt TH, García-Vallejo JJ, van Kooyk Y, Tannous BA, Wesseling P, Koppers-Lalic D, Vandertop WP, Noske DP, van Beusechem VW, van Rheenen J, Pegtel DM, van Tellingen O, Wurdinger T. Berenguer J, et al. Among authors: zoetemelk m. J Extracell Vesicles. 2018 Mar 13;7(1):1446660. doi: 10.1080/20013078.2018.1446660. eCollection 2018. J Extracell Vesicles. 2018. PMID: 29696074 Free PMC article.

8

Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostate.

McIlwain DW, Zoetemelk M, Myers JD, Edwards MT, Snider BM, Jerde TJ. McIlwain DW, et al. Among authors: zoetemelk m. Prostate. 2016 Jun;76(8):722-34. doi: 10.1002/pros.23161. Epub 2016 Feb 24. Prostate. 2016. PMID: 27088546 Free PMC article.

9

Expansion of prostate epithelial progenitor cells after inflammation of the mouse prostate.

Wang L, Zoetemelk M, Chitteti BR, Ratliff TL, Myers JD, Srour EF, Broxmeyer H, Jerde TJ. Wang L, et al. Among authors: zoetemelk m. Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1421-30. doi: 10.1152/ajprenal.00488.2014. Epub 2015 Apr 29. Am J Physiol Renal Physiol. 2015. PMID: 25925259 Free PMC article.

10

Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment.

van Beijnum JR, Weiss A, Berndsen RH, Wong TJ, Reckman LC, Piersma SR, Zoetemelk M, de Haas R, Dormond O, Bex A, Henneman AA, Jimenez CR, Griffioen AW, Nowak-Sliwinska P. van Beijnum JR, et al. Among authors: zoetemelk m. Cancers (Basel). 2020 Sep 21;12(9):2697. doi: 10.3390/cancers12092697. Cancers (Basel). 2020. PMID: 32967224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results